Ftse Mib
35.139,86
0,98%
DAX
20.297,04
0,79%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
96.578,30
2,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Biohaven Ltd (BHVN) Biohaven Ltd (BHVN) Notizie

Biohaven Ltd

BHVN
37,48
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:59:06
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202517:16EDGAR2Form 8-K - Current report
13/1/202517:15PRNUSBiohaven Highlights Portfolio Progress, Innovation, and..
13/1/202502:04GLOBEMerus and Biohaven Announce Collaboration to Co-Develop..
07/1/202523:54PRNUSBiohaven to Present at the 43rd Annual J.P. Morgan..
16/12/202413:30PRNUSBiohaven Reports Positive Phase 1 Degrader Data, Achieving..
06/12/202413:30PRNUSBiohaven Presents New Data with BHV-7000 Once-Daily..
25/11/202413:30PRNUSBiohaven Provides Update on Taldefgrobep Alfa Development..
12/11/202422:16EDGAR2Form 8-K - Current report
12/11/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05PRNUSBiohaven Reports Third Quarter 2024 Financial Results and..
02/10/202422:18EDGAR2Form 8-K - Current report
02/10/202422:05PRNUSBiohaven Announces Closing of Public Offering and Full..
01/10/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/10/202412:00PRNUSBiohaven Announces Pricing of $250 Million Public Offering..
30/9/202423:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/9/202422:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
30/9/202413:30PRNUSBiohaven Initiates Pivotal Trial of Novel Investigational..
24/9/202412:15IHMARKETNEWSVisa Faces Monopoly Lawsuit; Meta Introduces Celebrity..
23/9/202415:11EDGAR2Form 8-K - Current report
23/9/202413:30PRNUSBiohaven Achieves Positive Topline Results in Pivotal Study..
21/9/202401:09PRNUSBiohaven Announces Conference Call to Discuss Topline..
16/8/202422:35EDGAR2Form 8-K - Current report
16/8/202422:31EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
16/8/202422:25EDGAR2Form 8-K - Current report
16/8/202422:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:17EDGAR2Form 8-K - Current report
08/8/202422:05PRNUSBiohaven Reports Second Quarter 2024 Financial Results and..
29/5/202413:30PRNUSBiohaven Showcases Broad Innovative Portfolio and Pipeline..
29/5/202413:15PRNUSBiohaven Doses First Patient with its Novel Trop-2 Directed..
17/5/202422:42EDGAR2Form 8-K - Current report
17/5/202422:41EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
09/5/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:14EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSBiohaven Reports First Quarter 2024 Financial Results and..
22/4/202422:05PRNUSBiohaven Announces Closing of Public Offering and Full..
17/4/202422:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
13/4/202415:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
29/2/202422:16EDGAR2Form 8-K - Current report
29/2/202422:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
Apertura: Min: Max:
Chiusura: 37,48

La tua Cronologia

NYSE
BHVN
Biohaven
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network